BRK.B vs CRL · rev $371.44B vs rev $2.00B
BRK.B (BRK.B) versus Charles River Laboratories (CRL) — a side-by-side from cached financials, not a winner call.
BRK.B (BRK.B) common stock. It is led by Warren Buffett.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Latest reported BRK.B revenue for 2025-12-31 was $371.44B. Net income was $66.97B. Revenue was up 616.8% from 2015-12-31 to 2025-12-31. BRK.B currently screens at market cap $0.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
BRK.B currently screens at market cap $0. CRL currently screens at market cap $7.78B.
Not investment advice. Open the BRK.B and CRL stock pages for the full models.
Not investment advice.